↓ Skip to main content

Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial

Overview of attention for article published in European Heart Journal, September 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
19 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
326 Dimensions

Readers on

mendeley
208 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial
Published in
European Heart Journal, September 2013
DOI 10.1093/eurheartj/eht334
Pubmed ID
Authors

Maarten Groenink, Alexander W. den Hartog, Romy Franken, Teodora Radonic, Vivian de Waard, Janneke Timmermans, Arthur J. Scholte, Maarten P. van den Berg, Anje M. Spijkerboer, Henk A. Marquering, Aeilko H. Zwinderman, Barbara J.M. Mulder

Abstract

Patients with Marfan syndrome have an increased risk of life-threatening aortic complications, mostly preceded by aortic dilatation. Treatment with losartan, an angiotensin-II receptor-1 blocker, may reduce aortic dilatation rate in Marfan patients.

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 208 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 3 1%
United Kingdom 1 <1%
Canada 1 <1%
New Zealand 1 <1%
Singapore 1 <1%
Russia 1 <1%
Spain 1 <1%
Greece 1 <1%
Unknown 198 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 33 16%
Student > Ph. D. Student 24 12%
Other 21 10%
Student > Bachelor 21 10%
Student > Doctoral Student 20 10%
Other 55 26%
Unknown 34 16%
Readers by discipline Count As %
Medicine and Dentistry 115 55%
Biochemistry, Genetics and Molecular Biology 18 9%
Agricultural and Biological Sciences 15 7%
Nursing and Health Professions 5 2%
Engineering 4 2%
Other 11 5%
Unknown 40 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2022.
All research outputs
#2,282,004
of 24,598,501 outputs
Outputs from European Heart Journal
#2,903
of 10,705 outputs
Outputs of similar age
#19,607
of 203,834 outputs
Outputs of similar age from European Heart Journal
#26
of 121 outputs
Altmetric has tracked 24,598,501 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,705 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.0. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,834 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.